A gene mutation discovered in a small Amish community in Indiana has inspired the use of a new experimental drug for COVID-19 that reduces blood clotting.
In late March, the world came to a virtual standstill. The COVID-19 pandemic forced leaders around the world to limit large gatherings and shutter schools and businesses. For Feinberg’s research enterprise, this was a serious disruption — but science kept moving forward.
Second-year medical students Jeff Clark, Nathan Shlobin, and Steven Hoffman are the co-authors of a first of its kind study, which found that more than 80 percent of patients hospitalized with COVID-19 experienced neurological manifestations.
The Northwestern University Clinical and Translational Sciences (NUCATS) Institute hosted the first virtual COVID-19 symposium, which gave the Northwestern research community an opportunity to learn about efforts to advance public health and respond to the COVID-19 pandemic.
During a recent webinar, Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, discussed findings from the ongoing Screening for Coronavirus Antibodies in Neighborhoods (SCAN) study and what genetics can reveal about COVID-19.
In the face of the greatest public health crisis in a century, Feinberg’s Institute for Public Health and Medicine (IPHAM) mobilized with leading-edge science, new grant programs for community partners and a series of informational webinars.
A recent Northwestern Medicine perspective piece published in journal Academic Medicine discussed how the COVID-19 pandemic could impact gender equity within the field, specifically the retention and advancement of women.
Nicholas Soulakis, PhD, assistant professor of Preventive Medicine in the Divisions of Health and Biomedical Informatics and Epidemiology, discussed lessons learned from his experience leading COVID-19 contract tracing efforts for the Illinois Department of Public Health during a recent webinar.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety…
The COVID-19 contact tracing process, led by health departments across the state, and coordinated by the Illinois Department of Public Health, involves a team of dedicated team members tracking the spread of the disease.